| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.43 | 0.002 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.084 | 0.003 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |